{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:28:13Z","timestamp":1786717693191,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0973-1482.184522","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T11:10:01Z","timestamp":1486465801000},"page":"1278","source":"Crossref","is-referenced-by-count":4,"title":["Synergistic induction of apoptosis in B-cell chronic lymphocytic leukemia cells after treatment with all-trans retinoic acid in combination with interleukin-21 and rituximab"],"prefix":"10.4103","volume":"12","author":[{"given":"AliAkbar","family":"Saboor-Yaraghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Abbaszadeh-Goudarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazel","family":"Shokri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Ghalamfarsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.184522-1","first-page":"vii320","volume-title":"Chronic lymphocytic leukaemia: A short overview","author":"Montserrat","year":"2008","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1482.184522-2","first-page":"187","volume-title":"How I treat CLL up front","author":"Gribben","year":"2010","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-3","first-page":"279","volume-title":"The clinical and epidemiological burden of chronic lymphocytic leukaemia","author":"Redaelli","year":"2004","journal-title":"Eur J Cancer Care (Engl)"},{"key":"key-10.4103\/0973-1482.184522-4","first-page":"417","volume-title":"Caring for patients with chronic lymphocytic leukemia","author":"Elphee","year":"2008","journal-title":"Clin J Oncol Nurs"},{"key":"key-10.4103\/0973-1482.184522-5","first-page":"1164","volume-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trial","author":"Hallek","year":"2010","journal-title":"Lancet"},{"key":"key-10.4103\/0973-1482.184522-6","first-page":"975","volume-title":"Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia","author":"Tam","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-7","first-page":"227","volume-title":"Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation","author":"Pepper","year":"2002","journal-title":"Eur J Haematol"},{"key":"key-10.4103\/0973-1482.184522-8","first-page":"1007","volume-title":"Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+T cells as well as CD4+CD25+FoxP3+regulatory T cells toward an antileukemia response","author":"Hus","year":"2008","journal-title":"Leukemia"},{"key":"key-10.4103\/0973-1482.184522-9","first-page":"3708","volume-title":"Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells","author":"de","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-10","first-page":"2712","volume-title":"B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation","author":"Jahrsd\u00f6rfer","year":"2006","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-11","first-page":"4723","volume-title":"IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro","author":"Gowda","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-12","first-page":"1314","volume-title":"The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism","author":"Pedersen","year":"2002","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-13","first-page":"1038","volume-title":"The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: Evidence of caspase activation and apoptosis induction","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-14","first-page":"523","volume-title":"The 2008 WHO classification of lymphomas: Implications for clinical practice and translational research","author":"Jaffe","year":"2009","journal-title":"Hematology"},{"key":"key-10.4103\/0973-1482.184522-15","first-page":"5446","volume-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"key-10.4103\/0973-1482.184522-16","first-page":"219","volume-title":"Clinical staging of chronic lymphocytic leukemia","author":"Rai","year":"1975","journal-title":"Blood"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:27:25Z","timestamp":1786714045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-1482.184522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"alternative-id":["184522"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.184522","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}